Sustained β-catenin activation via GSK3 inhibition promotes direct fibroblast-to-cardiomyocyte reprogramming

Xinghua Wang1, Iqra Anwar1, Richard E Pratt1

  • 1Mandel Center for Heart and Vascular Research, and the Duke Cardiovascular Research Center, Duke University Medical Center, Durham, North Carolina, USA.

Insights

Direct cardiac reprogramming requires early inhibition of glycogen synthase kinase-3 (GSK3) to activate Wnt/β-catenin signaling, unlike iPSC differentiation. This approach enhances cardiomyocyte yield and maturation.

Area of Science:

  • Cardiovascular Research
  • Stem Cell Biology
  • Regenerative Medicine

Background:

  • Cardiomyocyte generation from induced pluripotent stem cells (iPSCs) involves transient Wnt/β-catenin signaling.
  • Understanding cardiac reprogramming pathways is crucial for regenerative therapies.

Purpose of the Study:

  • To investigate if Wnt/β-catenin signaling dynamics in iPSC differentiation apply to direct fibroblast-to-cardiomyocyte reprogramming.
  • To explore the role of glycogen synthase kinase-3 (GSK3) in direct cardiac reprogramming.

Main Methods:

  • Pharmacological inhibition of GSK3.
  • Reporter assays to assess β-catenin transcriptional activity.
  • Optical calcium mapping for functional maturation assessment.
  • Transcriptomic analysis.

Main Results:

  • Direct reprogramming requires early GSK3 inhibition for β-catenin activation, unlike iPSC differentiation.
  • GSK3 inhibition improved cardiomyocyte yield and functional maturation.
  • Transcriptomic analysis showed enrichment of muscle-related genes and altered immune/signaling pathways.

Conclusions:

  • Direct and indirect cardiac reprogramming share Wnt pathway involvement but differ significantly in temporal and mechanistic requirements.
  • Early GSK3 inhibition is a key factor for efficient direct cardiac reprogramming.